PD03: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II
Friday, May 15, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
206
Poster and Podium Sessions
BPHNew Technologies/Instruments/Devices
Information
Continuing Medical Education
CME
Friday, May 15
PD03-01: The MILES trial: Prospective randomized trial of safety and efficacy of minimally invasive versus standard laser enucleation of the prostate
Friday, May 15, 2026 9:30 AM to 9:38 AM
206
PD03-02: Multicenter 24-month outcomes of Rivermark FloStent™: the RAPID-II study
Friday, May 15, 2026 9:38 AM to 9:46 AM
206
PD03-03: Medical treatment of benign prostatic hyperplasia after bladder outlet procedures
Friday, May 15, 2026 9:46 AM to 9:54 AM
206
Mahir Maruf · Johns Hopkins
PD03-04: Downstream Effects: The Rate of Post-Procedural Urethral Stricture Rate After Aquablation® is Higher than Previously Reported
Friday, May 15, 2026 9:54 AM to 10:02 AM
206
PD03-05: Perioperative and Trifecta Outcomes of Single Port Transvesical Robotic Simple Prostatectomy: A Report from the Single Port Advanced Research Consortium
Friday, May 15, 2026 10:02 AM to 10:10 AM
206
PD03-06: Real-World Outcomes of Aquablation for Benign Prostatic Hyperplasia: A Comparative Analysis of the International Collaborative Aquablation Research Urology Society (ICARUS) database, WATER and WATER-II Trials
Friday, May 15, 2026 10:10 AM to 10:18 AM
206
PD03-07: Reintervention rates and patterns of reoperation following surgical management of benign prostatic hyperplasia
Friday, May 15, 2026 10:18 AM to 10:26 AM
206
Alka Tomar · Case Western Reserve University School of Medicine
PD03-08: Comparative outcomes of holmium laser enucleation (HoLEP), prostatic urethral lift (UroLift), Rezum, and transurethral resection of the prostate (TURP): a systematic review of evidence from 2015 to 2025
Friday, May 15, 2026 10:26 AM to 10:34 AM
206
PD03-09: Durable Symptom Relief and Functional Preservation: Final 3-Year Results from the PINNACLE Trial of the Optilume® BPH Catheter System
Friday, May 15, 2026 10:34 AM to 10:42 AM
206
PD03-10: Clinical evaluation of AI-based software for diagnosing bladder outlet obstruction and detrusor underactivity in men with lower urinary tract symptoms
Friday, May 15, 2026 10:42 AM to 10:50 AM
206
PD03-11: Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Taumsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia : Results of Multicenter, Randomized, Double-Blind, Phase III Clinical T
Friday, May 15, 2026 10:50 AM to 10:58 AM
206
PD03-12: Beyond Operative Time: NASA-TLX Workload Scores Reveal Cognitive and Physical Demands Across the HoLEP Learning Curve
Friday, May 15, 2026 10:58 AM to 11:06 AM
206
PD03-13: Ejaculation-Sparing Thulium Laser Enucleation of the Prostate (ES-ThuLEP): A Feasible and Effective Alternative for BPH Treatment
Friday, May 15, 2026 11:06 AM to 11:14 AM
206
PD03-14: Durability of holmium laser enucleation of the prostate: A 10-year multi-institutional comparison using the Cosmos Database
Friday, May 15, 2026 11:14 AM to 11:22 AM
206
PD03-15: How to avoid complications during Robotic Waterjet ablation therapy (Aquablation) in BPH patients?
Friday, May 15, 2026 11:22 AM to 11:30 AM
206
